Saudi universities secure top honors at Geneva exhibition
Their wins, achieved in a field of 900 inventors from 40 countries, underscore the Kingdom's growing global scientific influence.
PNU claimed four medals, including a silver medal for Dr. Sarah Al-Nufaiei's 'fixed dental reference marker' — a pioneering tool that standardizes dental implant placements by creating fixed intraoral reference points, improving precision in restorative procedures.
The university was also awarded three bronze medals for transformative projects. Dr. Haya Al-Shahrani's 'smart wheelchair controlled via brain signals and eye blinks wirelessly' uses non-invasive EEG sensors and eye-tracking cameras to empower mobility-impaired users.
Dr. Fahda Al-Qahtani's 'gum-based tool for isolating structurally damaged teeth' provides a biocompatible alternative to traditional rubber dam clamps, while Dr. Taghreed Al-Omar's 'anti-diabetic drug formulation with Friedelin (a chemical compound)' isolates the triterpenoid compound from Ziziphus spina-christi leaves to improve glycemic control.
These innovations align with PNU's 2025 strategic plan to advance Saudi Arabia's sustainable development goals and position the university as a center for women-led STEM breakthroughs.
Najran University won a gold medal for its 'nano-photocatalyst using date palm seed bio-carbon with gold nanoparticles and zinc oxide for industrial wastewater treatment.'
The project addresses environmental challenges by converting locally sourced date palm seeds into bio-carbon — a sustainable base material — then augmenting it with gold nanoparticles and zinc oxide to create a photocatalyst that degrades organic pollutants under UV light.
This low-cost, solar-powered solution underscores Saudi Arabia's commitment to eco-innovation under Vision 2030.
The event featured 161 Saudi participants from schools, universities and technical institutes, showing advances in AI-driven infrastructure, healthcare robotics, and biometric security systems.
With both universities now eyeing international patents and commercial partnerships, Saudi academia's footprint on the world stage continues to grow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Asharq Al-Awsat
3 hours ago
- Asharq Al-Awsat
KACST Manufactures 25 Advanced Electronic Chips by Saudi Talents
Saudi Arabia's King Abdulaziz City for Science and Technology (KACST) announced on Thursday its successful design and fabrication of 25 advanced electronic chips, developed by Saudi talents in its cleanroom laboratories for purposes of training, research, and development. The achievement is part of KACST's ongoing efforts to support and enable the semiconductor ecosystem in the Kingdom. These chips are distinguished by their versatility and can be used in a range of applications, including electronics, wireless and high-frequency communications, integrated circuits, energy-efficient lighting, micro-sensor systems, as well as industrial and research applications in measurement and testing. The chip design process involved researchers from the National Laboratory, alongside students from four Saudi universities. This effort was conducted under the initiatives of the Saudi Semiconductors Program (SSP), which aims to build national expertise in this critical field. The chips can be used in a range of applications. (SPA) This milestone is part of a series of strategic initiatives led by KACST to support the semiconductor sector in the Kingdom, including the Saudi Semiconductors Program to boost research and development and qualify human talent and the "Ignition" semiconductor incubator program to support startups and entrepreneurs. Through these initiatives, KACST underscored its commitment to the ambitious goals of Saudi Vision 2030 by localizing strategic technologies, empowering national talent, and achieving technological self-sufficiency in advanced domains.
Arab News
13 hours ago
- Arab News
Saudis make electronic chips at KACST
RIYADH: King Abdulaziz City for Science and Technology has designed and produced 25 advanced electronic chips which had been developed in laboratories by Saudis for training, research, and development purposes. The achievement is part of the establishment's efforts to support and empower the semiconductor ecosystem in the Kingdom. The chips are distinguished by their potential applications in various fields, such as electronics, wireless and high-frequency communications, integrated circuits, energy-efficient lighting, and miniaturized sensing systems, in addition to industrial and research applications in measurement and testing. The design of the chips involved researchers from the national laboratory, along with a number of students from four Saudi universities. It formed part of the initiatives integral to the Saudi Semiconductors Program, which aims to qualify national talents in this vital field.
Makkah Newspaper
a day ago
- Makkah Newspaper
Saudi Arabia's Pharma Leap to Global Leadership
Dear reader, over the past decade, Saudi Arabia has undertakenan ambitious overhaul of its healthcare and life sciences landscape. Guided by Vision 2030, the Kingdom is positioning itself as a knowledge‑driven economy with a robust, self‑reliant pharmaceutical sector. Recent data from IQVIA andEuromonitor highlight progress on several key fronts, including market expansion, manufacturing capacity, hospital infrastructure, and tender market dynamics. Here's a closer look at the numbers and why they matter. Across the broader Middle East and Africa (MEA) region, pharmaceutical sales increased from USD 24.2 billion in 2020 to USD 29.5 billion in 2023 and are projected to surpass USD 32.6 billion in 2024, representing a cumulative growth of approximately 35% over the four years. Saudi Arabia is the primary growth driver, with the Kingdom's share increasing from USD 8.7 billion to USD 11.6 billion, underscoring strong domestic demand and rising purchasing power. The UAE, SouthAfrica, and Algeria follow closely, while smaller markets, such as Lebanon, Jordan, and Kuwait, are expanding steadily from a lower base. Dear reader, Zooming in on Saudi Arabia's five largest therapy areas, combined sales rose from about USD 3.8 billion in 2019 to a forecasted USD 5.6 billion by 2026 (a 6.5 % compound annual growth rate). General medicines alone are expected to exceed USD 2.8 billion by 2026, followed by consumer health products at roughly USD 750 million, driven by trends in preventive care and wellness. Dermatology, digestive health, and ophthalmology remain smaller niches, but they are growing at 5–7% per year as urban lifestyles increase demand for allergy treatments and chronic disease medications. Government tenders remain the backbone of public procurement, valued at approximately USD 5.6 billion. Two multinationals, Hikma and Sanofi, lead with 9 % share each. Local champions SPIMACO (8%) and Tabuk Pharmaceuticals (7%) rank closely behind, while Pfizer, Novo Nordisk, and Novartis each hold 5–6%. At the other end of the scale, Jamejoom Pharma captures just 1 %, signaling headroom for domestic firms to ramp up portfolios tailored to tender specifications. Dear reader, domestic production is spreading across a broader base of players (over 2,100 registered items). Pharmaceutical Solution Industries (PSI) tops the chart with 21% of national output, followed by Tabuk (18%) and SPIMACO (15%).Jamejoom, Riyadh Pharma, and Jazeera Pharma each command roughly 8–9 %, while a long tail of other manufacturers together accounts for 20 %. The distribution highlights Ministry of Industry incentives to increase local content, promote innovation, and enhance exports, particularly following the launch of the National Biotechnology Strategy. Dear reader, several forces are converging: sweeping healthcarefinancing reforms, incentives for local manufacturing that deepen supply chain resilience, a welcoming stance toward foreign direct investment, and rapid digital adoption, from telemedicine to e-prescriptions. Although rising healthcare costs and chronic disease burdens pose challenges, current indicators suggest an ample runway for both local and international drugmakers, especially in biologics, targeted therapies, and self-care products. Saudi Arabia is charting a course to become the region's premier hub for pharmaceutical innovation and high‑quality healthcare services. With a sizable domestic market, expanding infrastructure, and policies favorable to private enterprise, the Kingdom could, by the end of the decade, rank among the most attractive healthcare markets in the broader Middle East and North Africa. In short, the 'Saudi pharma leap' is no longer aspirational rhetoric; it is unfolding on the ground. Continued execution will be vital, but the trajectory points to a future where Saudi Arabia not only meets local medical needs more efficiently but also exports health solutions to the world.
